Schnitzler's syndrome improvement after anti-TNF-alpha therapy

Joint Bone Spine. 2010 Oct;77(5):491. doi: 10.1016/j.jbspin.2010.02.016. Epub 2010 May 15.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adalimumab
  • Adult
  • Anti-Infective Agents / administration & dosage
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents / therapeutic use*
  • Dapsone / administration & dosage
  • Drug Therapy, Combination
  • Etanercept
  • Humans
  • Immunoglobulin G / administration & dosage
  • Male
  • Prednisone / administration & dosage
  • Pulse Therapy, Drug
  • Receptors, Tumor Necrosis Factor / administration & dosage
  • Schnitzler Syndrome / blood
  • Schnitzler Syndrome / diagnosis
  • Schnitzler Syndrome / drug therapy*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Anti-Infective Agents
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Dapsone
  • Adalimumab
  • Etanercept
  • Prednisone